Seres Therapeutics, Inc.
For the period ended Jun 2, 2026. Filed Jun 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jun 2, 2026 · Filed Jun 5, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Lease Restructuring
Lease Restructuring
Seres has amended its lease with its landlord for the Company’s facility at 101 CambridgePark Drive in Cambridge, Massachusetts, reducing its leased space, rental rate and facility operating expenses. Under the amended arrangement, Seres will lease the retained space for a 10-year term at market-adjusted annual rent and a lower percentage of shared operating expenses for the building as of May 1, 2026, in exchange for the landlord drawing the existing letter of credit, Seres payment of a termination fee and the establishment of a new letter of credit.** **The restructured lease is expected to materially reduce the Company’s ongoing annual facility-related costs and long-term obligations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.